AstraZeneca shares fall on report of potential China probe fallout/Chief of AZ China in custody might be unrelated
AstraZeneca AZN-Q shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker’s senior executives in China could be implicated in the largest insurance fraud case in the country’s pharma sector in years. The Anglo-Swedish company, which has invested heavily in the world’s No. 2 pharmaceuticals market, said …